RNAM vs. NEON

Last updated Jun 3, 2026

RNAM (Avidity Biosciences, Inc.) and NEON (Neonode Inc.) are both stocks. RNAM operates in Biotechnology (Healthcare), while NEON operates in Electronic Components (Technology).

Performance

RNAM vs. NEON - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avidity Biosciences, Inc. (RNAM) and Neonode Inc. (NEON). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

RNAM

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

NEON

• 1D: -0.61%
• 1M: -2.96%
• YTD: -5.75%
• 6M: -25.11%
• 1Y: -84.56%
• 3Y*: -41.96%
• 5Y*: -23.08%
• 10Y*: -20.99%

*Multi-year figures are annualized to reflect compound growth (CAGR)

RNAM vs. NEON - Yearly Performance Comparison

	2026 (YTD)
RNAM Avidity Biosciences, Inc.	0.00%
NEON Neonode Inc.	-13.23%

Fundamentals

Market Cap RNAM : $10.87B NEON : $27.52M
EPS RNAM : -$4.93 NEON : $0.50
PS Ratio RNAM : 539.42 NEON : 12.72
PB Ratio RNAM : 6.44 NEON : 1.20
Total Revenue (TTM) RNAM : $18.76M NEON : $2.16M
Gross Profit (TTM) RNAM : $14.60M NEON : $1.81M
EBITDA (TTM) RNAM : -$741.79M NEON : $7.89M

Return for Risk

RNAM vs. NEON — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NEON

NEON Risk / Return Rank: 11
NEON Sharpe Ratio Rank: 11
NEON Sortino Ratio Rank: 11
NEON Omega Ratio Rank: 8
NEON Calmar Ratio Rank: 7
NEON Martin Ratio Rank: 18

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RNAM vs. NEON - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avidity Biosciences, Inc. (RNAM) and Neonode Inc. (NEON). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	RNAM	NEON	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.69	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.22	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.21	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.22	—

Drawdowns

Drawdown Indicators

	RNAM	NEON	Difference
Max Drawdown Largest peak-to-trough decline	—	-99.93%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-95.67%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-95.67%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-95.67%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-95.67%	—
Current Drawdown Current decline from peak	—	-99.90%	—
Average Drawdown Average peak-to-trough decline	—	-96.76%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	79.87%	—

Volatility

Volatility by Period

	RNAM	NEON	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	23.16%	—
Volatility (6M) Calculated over the trailing 6-month period	—	42.67%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	123.05%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	107.56%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	98.85%	—

Dividends

RNAM vs. NEON - Dividend Comparison

Neither RNAM nor NEON has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials